Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vaccinex, Inc. (VCNX)

1.06   -0.02 (-1.85%) 06-29 17:49
Open: 1.05 Pre. Close: 1.08
High: 1.1 Low: 1.03
Volume: 50,851 Market Cap: 45(M)
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.1 - 1.11 1.11 - 1.11
Low: 1.01 - 1.02 1.02 - 1.03
Close: 1.05 - 1.06 1.06 - 1.07

Technical analysis

as of: 2022-06-29 4:58:23 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.43     One year: 1.6
Support: Support1: 1    Support2: 0.83
Resistance: Resistance1: 1.22    Resistance2: 1.37
Pivot: 1.12
Moving Average: MA(5): 1.09     MA(20): 1.17
MA(100): 1.27     MA(250): 1.64
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 21.9     %D(3): 26.3
RSI: RSI(14): 41.1
52-week: High: 2.68  Low: 0.89
Average Vol(K): 3-Month: 110 (K)  10-Days: 95 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VCNX ] has closed above bottom band by 26.9%. Bollinger Bands are 28.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 28 Jun 2022
BioVie : Regulation FD Presentation - Form 8-K - Marketscreener.com

Thu, 09 Jun 2022
Is Vaccinex Inc (VCNX) a Laggard in the Healthcare Sector? - InvestorsObserver

Wed, 01 Jun 2022
Is Vaccinex Inc (VCNX) Stock a Bad Value? - InvestorsObserver

Mon, 25 Apr 2022
Vaccinex, Inc. Announces Upcoming Presentation at the PEGS Boston Conference & Expo Highlighting Its ActivMAb® Technology for Complex Membrane Antigen Expression to Enable Drug Discovery - GlobeNewswire

Thu, 31 Mar 2022
Vaccinex Reports 2021 Financial Results and Provides Corporate Update - GlobeNewswire

Wed, 09 Mar 2022
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 31 (M)
% Held by Insiders 2.618e+007 (%)
% Held by Institutions 12 (%)
Shares Short 818 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -2.232e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -2
Return on Assets (ttm) 498.8
Return on Equity (ttm) -130.5
Qtrly Rev. Growth 900000
Gross Profit (p.s.) 0
Sales Per Share -790.26
EBITDA (p.s.) -1.37797e+007
Qtrly Earnings Growth -1
Operating Cash Flow 0 (M)
Levered Free Cash Flow -25 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 3.2

Stock Dividends

Dividend 0
Forward Dividend 564830
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.